RTALB.E.IS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 18, 2025
Report Source: 2025 1st Quarter Report
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS. Stock Analysis RTALB.E.IS
Turkey Health Care Nano Cap Report: RTA Laboratuvarlari Biyolojik Ürünler Ilaç ve Makine Sanayi Ticaret AS engages in the production, research, and development in vitro diagnostics. Its diagnostic products include: Clinical Microbiology, such as chromogenic media, culture media in petri dishes, tubes and bottles, rodac petri surcheck, and tuberculosis diagnosis products; ELISA Kits, such as HBsAg ELISA Kit; Molecular Diagnostics, such as nucleic acid isolation kits, real-time PCR instruments, real-time PCR kits and RTA VOLTRAN voral detection system, as well as other tests. Its Research includes: dehydrated culture media, such as dehydrated chromogenic culture media; nucleic acid isolation kits and real-time PCR.
Read More RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS (RTALB.E.IS) Chart
Key Statistics of RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS (RTALB.E.IS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
TRY4.50Volume
131.46MP/E Ratio (TTM)
2.6752 Week Range
Market Cap
1.62BAvg. Volume
76.92MDividend Yield
-Financial Metrics & Statements of RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS (RTALB.E.IS)
FAQ's for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS (RTALB.E.IS)
- According to Musaffa’s Shariah screening methodology, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS (RTALB.E.IS) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.